СЕРДЦЕ И ВОЗРАСТ (ЧАСТЬ II): КЛИНИЧЕСКИЕ ПРОЯВЛЕНИЯ СТАРЕНИЯ
https://doi.org/10.15829/1728-8800-2013-4-86-90
Аннотация
Старение – процесс закономерный и неизбежный, ухудшающий качество жизни и сокращающий ее продолжительность. Сердце с возрастом также претерпевает ряд изменений, которые снижают его компенсаторные возможности и способствуют развитию болезни. Такие изменения структуры и функции сердца, наблюдаемые в отсутствие сердечно-сосудистых заболеваний (CCЗ), принято относить к возрастным. Однако, учитывая высокую распространенность ССЗ у пожилых людей, определить истинное старение сердца трудно. В данном обзоре выделен ряд субклинических состояний, которые часто наблюдаются у пожилых людей.
Ключевые слова
Об авторах
Д. У. Акашева
ФГБУ “Государственный научно-исследовательский центр профилактической медицины” Минздрава России, Москва
Россия
Россия
с. н.с. сотрудник отдела комплексного снижения риска неинфекционных заболеваний
Тел.: 8 (903) 526–44–81
Е. В. Плохова
ФГБУ “Государственный научно-исследовательский центр профилактической медицины” Минздрава России, Москва
Россия
аспирант отдела
Россия
аспирант отдела
И. Д. Стражеско
ФГБУ “Государственный научно-исследовательский центр профилактической медицины” Минздрава России, Москва
Россия
к. м.н., в. н.с. отдела
Россия
к. м.н., в. н.с. отдела
Е. Н. Дудинская
ФГБУ “Государственный научно-исследовательский центр профилактической медицины” Минздрава России, Москва
Россия
к. м.н., н. с. отдела
Россия
к. м.н., н. с. отдела
О. Н. Ткачева
ФГБУ “Государственный научно-исследовательский центр профилактической медицины” Минздрава России, Москва
Россия
д. м.н., проф., руководитель отдела
Россия
д. м.н., проф., руководитель отдела
Список литературы
1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation 2003; 107: 139–46.
2. Lakatta EG. Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev 2002; 7 (1): 29–49.
3. Dannenberg AL, Levy D, Garrison RJ. Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study). Am J Cardiol 1989; 64: 1066–8.
4. Olivetti G, Melissari M, Capasso J, et al. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 1991; 68: 1560–8.
5. Khouri MG, Maurer MS, El-Khoury Rumbarger L. Assessment of agerelated changes in left ventricular structure and function by freehand threedimensional echocardiography. Am J Geriatr Cardiol 2005; 14 (3): 118–25.
6. Nikitin NP, Loh PH, de Silva R, et al. Left ventricular morphology, global and longitudinal function in normal older individuals: a cardiac magnetic resonance study. Int J Cardiol 2006; 108 (1): 76–83.
7. Ganau A, Saba PS, Roman MJ, et al. Ageing induces left ventricular concentric remodeling in normotensive subjects. J Hypertens 1995; 13: 1818–22.
8. Hees PS, Fleg JL, Lakatta EG, et al. Left ventricular remodeling with age in normal men versus women: novel insights using three-dimensional magnetic resonance imaging. Am J Cardiol 2002; 90 (11): 1231–6.
9. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation 2003; 107: 490–7.
10. Younis LT, Melin JA, Robert AR, et al. In uence of age and sex on left ventricular volumes and ejection fraction during upright exercise in normal subjects. Eur Heart J 1990; 11: 916–24.
11. Ruan Q, Nagueh SF. Effect of age on left ventricular systolic function in humans: a study of systolic isovolumic acceleration rate. Exp Physiol 2005; 90 (4): 527–34.
12. Oxenham H, Sharpe N. Cardiovascular aging and heart failure. Eur J Heart Fail 2003; 5 (4): 427–34.
13. Stratton JR, Levy WC, Cerqueira MD, et al. Cardiovascular responses to exercise. Effects of aging and exercise training in healthy men. Circulation 1994; 89: 1648–55.
14. Takeuchi M, Nakai H, Kokumai M, et al. Age-related changes in left ventricular twist assessed by two-dimensional speckle-tracking imaging. J Am Soc Echocardiogr 2006; 19: 1077–84.
15. Helle-Valle T, Crosby J. New Noninvasive Method for Assessment of Left Ventricular Rotation: Speckle Tracking Echocardiography. Circulation 2005; 112: 3149–56.
16. van Dalen BM, Soliman OI, Vletter WB, et al. Insights into left ventricular function from the time course of regional and global rotation by speckle tracking echocardiography. Echocardiography 2009; 26: 371–7.
17. Schirmer H, Lunde P, Rasmussen K. Mitral flow derived Doppler indices of left ventricular diastolic function in a general population; the Tromso study. Eur Heart J 2000; 21: 1376–86.
18. Burlew BS. Diastolic dysfunction in the elderly – the interstitial issue. Am J Geriatr Cardiol 2004; 13: 29–38.
19. Lindsey ML, Goshorn DK, Squires CE, et al. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase pro les and broblast function. Cardiovasc Res 2005; 66: 410–9.
20. Dai DF, Santana LF, Vermulst M, et al. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 2009; 119: 2789–97.
21. Little WC, Warner JG, Rankin KM, et al. Evaluation of left ventricular diastolic function from the pattern of left ventricular filling. Clin Cardiol 1998; 21: 5–9.
22. Deswal A. Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiology. Curr Cardiol Rep 2005; 7 (3): 178–83.
23. Spiecker M. Heart failure in elderly patients. Exp Gerontol 2006; 41 (5): 549–51.
24. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 121: 951–7.
25. Rich MW. Heart failure in the 21st century: a cardiogeriatric syndrome. J Gerontol A Biol Sci Med Sci 2001; 56: M88–96.
26. Kitzman DW. Diastolic heart failure in the elderly. Heart Fail Rev 2002; 7 (1): 17–27.
27. Wong LS, van der Harst P, de Boer RA, et al. Aging, telomeres and heart failure. Heart Fail Rev 2010; 15 (5): 479–86.
28. van der Harst P, de Boer RA, Samani NJ, et al. Telomere length and outcome in heart failure. Ann Med 2010; 42: 36–44.
29. Chimenti C, Kajstura J, Torella D, et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res 2003; 93: 604–13.
30. Nassimiha D, Aronow WS, Ahn C, et al. Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol 2001; 87: 1313–4.
31. Freeman RV and Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111: 3316–26.
32. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341: 142–7.
33. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: A population-based study. Lancet 2006; 3689: 1005–11.
34. Rajamannan NM, Bonow RO, Rahimtoola SH. Calcific aortic stenosis: An update. Nat Clin Pract Cardiovasc Med 2007; 45: 254–62.
35. Drolet MC, Arsenault M, Couet J. Experimental valve stenosis in rabbits. JACC 2003; 41: 1211–7.
36. Rosseb A, Pedersen T, Bomanetal K. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359: 1343–56.
37. Ngo DT, Sverdlov AL, Willoughby SR, et al. Determinants of occurrence of aortic sclerosis in an aging population. JACC Cardiovasc Imaging 2009; 2 (8): 919–27.
38. Owens DS, Otto CM. Is it time for a new paradigm in calcific aortic valve disease? JACC Cardiovasc Imaging 2009; 2 (8): 928–30.
39. Kurz DJ, Kloeckener-Gruissem B, Akhmedov A, et al. Degenerative aortic valve stenosis, but not coronary disease, is associated with shorter telomere length in the elderly. Arterioscler Thromb Vasc Biol 2006; 26: e114–7.
40. Nassimiha D, Aronow WS, Ahn C, et al. Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol 2001; 87: 1313–4.
41. Dao-Fu Dai, Tony Chen, SimonC. Johnson, et al. Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease. Antioxidants & Redox Signaling 2012; 16 (12): 1492–526.
42. Guize L, Piot O, Lavergne T, et al. Cardiac arrhythmias in the elderly. Bull Acad Natl Med 2006; 190 (4–5): 827–41.
43. Manolio TA, Furberg CD, Rautaharju PM, et al. Cardiac arrhythmias on 24-hr ambulatory electrocardiography in older women and men: The Cardiovascular Health Study. JACC 1994; 23: 916–25.
44. Yanni J, Tellez JO, Sutyagin PV, et al. Structural remodelling of the sinoatrial node in obese old rats. J Mol Cell Cardiol 2010; 48 (4): 653–62.
45. Pollock ML, Mengelkoch LJ, Graves JE, et al. Twenty-year follow-up of aerobic power and body composition of older track athletes. J Appl Physiol 1997; 82 (5): 1508–16.
46. Kusumoto FM, Phillips R, Goldschlager N. Pacing therapy in the elderly. Am J Geriatr Cardiol 2002; 11: 305–16.
47. Lamas GA, Lee K, Sweeney M, et al. The Mode Selection Trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J 2000; 140: 541–51.
48. Craft N, Schwartz JB. Effects of age on intrinsic heart rate, heart rate variability, and AV conduction in healthy humans. Am J Physiol 1995; 268: H1441–52.
49. Gosse P, Coulon P, Papaioannou G, et al. Atrioventricular conduction in the hypertensive patient: influence of aging, pulse pressure, and arterial stiffness. Rejuvenation Res 2011; 14 (4): 405–10.
50. Ikolaos Fragakis, George Katsaris. Arrhythmias in the Elderly. Modern Management. Hellenic J Cardiol 2006; 47: 84–92.
51. Nicolini P, Ciulla MM, De Asmundis C, et al. The prognostic value of heart rate variability in the elderly, changing the perspective: from sympathovagal balance to chaos theory. Pacing Clin Electrophysiol 2012; 35 (5): 622–38.
52. Lakatta EG, Levy D. Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises. Part II: The Aging Heart in Health: Links to Heart Disease. Circulation 2003; 107: 346–54.
53. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27: 949–53.
54. Allessie MA, Boyden PA, Camm AJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103: 769–77.
55. Jais P, Peng JT, Shah DC, et al. Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation. J Cardiovasc Electrophysiol 2000; 11: 623–5.
56. Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90 (12): 1284–9.
57. Yamada T, Fukunami M, Shimonagata T, et al. Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study. JACC 2000; 35: 405–13.
Рецензия
Для цитирования:
Акашева Д.У., Плохова Е.В., Стражеско И.Д., Дудинская Е.Н., Ткачева О.Н. СЕРДЦЕ И ВОЗРАСТ (ЧАСТЬ II): КЛИНИЧЕСКИЕ ПРОЯВЛЕНИЯ СТАРЕНИЯ. Кардиоваскулярная терапия и профилактика. 2013;12(4):86-90. https://doi.org/10.15829/1728-8800-2013-4-86-90
For citation:
Akasheva D.U., Plokhova E.V., Strazhesko I.D., Dudinskaya E.N., Tkacheva O.N. HEART AND AGE (PART II): CLINICAL MANIFESTATIONS OF AGEING. Cardiovascular Therapy and Prevention. 2013;12(4):86-90. (In Russ.) https://doi.org/10.15829/1728-8800-2013-4-86-90
Просмотров:
2643
Послать статью по эл. почте 
